الفهرس Only 14 pages are availabe for public view
 |  | from | 134 |  |  |
| | | from | 134 | | |
Abstract
This Prospective comparative randomized study was conducted upon 100 patients; 50 of them will be managed by intradiscal injection of platelet rich plasma 2PRP3 and the other half by platelet rich fibrin 2PRF3 at Kasr Alaini hospital between January 2017 and June 2018. Visual analogue scale for pain will be applied to compare between the results of platelet rich plasma 2PRP3 and platelet rich fibrin 2PRF3. The purpose of this study was to introduce and summarize comparison between intradiscal injection of PRP and PRF which showed better results towards the PRF. Our study supports the idea of the safety of intradiscal injection of PRP and PRF and compares in the outcome achieved by both methods. These procedures can be done as a day procedure in about 30 minutes and are about one tenth the cost of a spinal fusion. A large economic burden may be lifted from the healthcare system. We can concluded that, biologic therapies such as PRP and PRF not only offer hope for the improvement to the most common, most costly and most disabling musculoskeletal condition faced by clinicians and patients, namelydiscogenic low back pain (DLBP), but may also offer national healthcare systems a cost-effective, sustainable solution to the management of DLBP